These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 19522503

  • 1. DNA structure and integrity checkpoints during the cell cycle and their role in drug targeting and sensitivity of tumor cells to anticancer treatment.
    Skladanowski A, Bozko P, Sabisz M.
    Chem Rev; 2009 Jul; 109(7):2951-73. PubMed ID: 19522503
    [No Abstract] [Full Text] [Related]

  • 2. Stopping replication, at the beginning.
    Jackson PK.
    Nat Chem Biol; 2008 Jun; 4(6):331-2. PubMed ID: 18488006
    [No Abstract] [Full Text] [Related]

  • 3. DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy.
    Ashwell S, Zabludoff S.
    Clin Cancer Res; 2008 Jul 01; 14(13):4032-7. PubMed ID: 18593978
    [Abstract] [Full Text] [Related]

  • 4. Promises and drawbacks of targeting cell cycle kinases in cancer.
    Pentimalli F, Giordano A.
    Discov Med; 2009 Dec 01; 8(43):177-80. PubMed ID: 20040266
    [Abstract] [Full Text] [Related]

  • 5. Cdc7 as a potential new target for cancer therapy.
    Ito S, Taniyami C, Arai N, Masai H.
    Drug News Perspect; 2008 Nov 01; 21(9):481-8. PubMed ID: 19180266
    [Abstract] [Full Text] [Related]

  • 6. A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells?
    O'Connor PM, Kohn KW.
    Semin Cancer Biol; 1992 Dec 01; 3(6):409-16. PubMed ID: 1286161
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of drug inhibition of signalling molecules.
    Sebolt-Leopold JS, English JM.
    Nature; 2006 May 25; 441(7092):457-62. PubMed ID: 16724058
    [Abstract] [Full Text] [Related]

  • 8. Targeting the cell cycle: a new approach to cancer therapy.
    Schwartz GK, Shah MA.
    J Clin Oncol; 2005 Dec 20; 23(36):9408-21. PubMed ID: 16361640
    [Abstract] [Full Text] [Related]

  • 9. Targeted cancer therapies based on the inhibition of DNA strand break repair.
    O'Connor MJ, Martin NM, Smith GC.
    Oncogene; 2007 Dec 10; 26(56):7816-24. PubMed ID: 18066095
    [Abstract] [Full Text] [Related]

  • 10. DNA damage checkpoints: from initiation to recovery or adaptation.
    Bartek J, Lukas J.
    Curr Opin Cell Biol; 2007 Apr 10; 19(2):238-45. PubMed ID: 17303408
    [Abstract] [Full Text] [Related]

  • 11. Targeting SMARCAL1 as a novel strategy for cancer therapy.
    Zhang L, Fan S, Liu H, Huang C.
    Biochem Biophys Res Commun; 2012 Oct 19; 427(2):232-5. PubMed ID: 22995303
    [Abstract] [Full Text] [Related]

  • 12. New checkpoint blockers begin human trials.
    Garber K.
    J Natl Cancer Inst; 2005 Jul 20; 97(14):1026-8. PubMed ID: 16030295
    [No Abstract] [Full Text] [Related]

  • 13. [Molecular mechanism regulating effect of anti-cancer agents].
    Saya H.
    Gan To Kagaku Ryoho; 2009 Jan 20; 36(1):1-5. PubMed ID: 19151557
    [Abstract] [Full Text] [Related]

  • 14. Targeting the DNA damage response in cancer.
    Ljungman M.
    Chem Rev; 2009 Jul 20; 109(7):2929-50. PubMed ID: 19545147
    [No Abstract] [Full Text] [Related]

  • 15. Chemical strategies for development of ATR inhibitors.
    Llona-Minguez S, Höglund A, Jacques SA, Koolmeister T, Helleday T.
    Expert Rev Mol Med; 2014 May 09; 16():e10. PubMed ID: 24810715
    [Abstract] [Full Text] [Related]

  • 16. Targeting DNA damage and repair: embracing the pharmacological era for successful cancer therapy.
    Aziz K, Nowsheen S, Pantelias G, Iliakis G, Gorgoulis VG, Georgakilas AG.
    Pharmacol Ther; 2012 Mar 09; 133(3):334-50. PubMed ID: 22197993
    [Abstract] [Full Text] [Related]

  • 17. Cell-cycle control in the face of damage--a matter of life or death.
    Clarke PR, Allan LA.
    Trends Cell Biol; 2009 Mar 09; 19(3):89-98. PubMed ID: 19168356
    [Abstract] [Full Text] [Related]

  • 18. [Target molecules of anti-tumor drugs and cell checkpoints].
    Sugimoto K.
    Rinsho Ketsueki; 2001 May 09; 42(5):356-8. PubMed ID: 11452450
    [No Abstract] [Full Text] [Related]

  • 19. [Resistance to cytostatic drugs].
    Elonen E.
    Duodecim; 1998 May 09; 114(13):1319-28. PubMed ID: 11552258
    [No Abstract] [Full Text] [Related]

  • 20. Cell-cycle checkpoints and cancer.
    Kastan MB, Bartek J.
    Nature; 2004 Nov 18; 432(7015):316-23. PubMed ID: 15549093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.